Do vitamin B12 and folate deficiencies raise homocysteine and cause macrocytosis and increased RDW?

The interplay between Vitamin B12 and folate is a cornerstone of one-carbon metabolism, serving as the regulatory hub for both DNA synthesis and amino acid recycling. In a 71-year-old female, maintaining these pathways is particularly critical for hematological stability and metabolic health.

The Remethylation Mechanism

Vitamin B12 and folate function as essential co-factors in the methionine cycle. The enzyme methionine synthase (MTR) utilizes folate (as 5-methyltetrahydrofolate) as a methyl donor and B12 (as methylcobalamin) as an intermediate carrier to convert homocysteine into the essential amino acid methionine.

• Biochemical pathway: Methylcobalamin transfers a methyl group to homocysteine, a reaction that simultaneously regenerates tetrahydrofolate (THF), which is required for nucleotide synthesis.
• Metabolic bottleneck: When availability is impaired, the MTR enzyme cannot function, leading to a "folate trap" and the systemic accumulation of homocysteine.

Clinical and Hematological Impact

A deficiency in these vitamins manifests as distinct metabolic and hematological markers that often precede clinical symptoms.

• Hyperhomocysteinemia: Evidence shows a strong inverse correlation between B12/folate levels and total homocysteine (tHcy). In elderly cohorts, elevated homocysteine is highly prevalent, often exceeding 15 µmol/L when vitamin stores are suboptimal.
• Megaloblastic Changes: B12 and folate are vital for thymidine synthesis. Deficiency inhibits DNA replication, causing "nuclear-cytoplasmic asynchrony" where red blood cell nuclei mature slower than the cytoplasm.
• Macrocytosis and RDW: This results in macrocytosis (Mean Corpuscular Volume/MCV > 100 fL). An increased Red Cell Distribution Width (RDW) often occurs early in the deficiency as a mixture of normal and enlarged cells (anisocytosis) enters circulation.

Bottom line

The claim is robustly supported: Vitamin B12 and folate are the primary regulators of homocysteine remethylation. Deficiency leads to elevated homocysteine and characteristic hematological shifts, including macrocytosis and increased RDW, driven by impaired DNA synthesis in the bone marrow.